Parker Hannifin
PH
$852.56
-0.68%
Parker-Hannifin Corporation is a global leader in motion and control technologies, designing and manufacturing precision-engineered components and systems for a wide range of industrial, aerospace, and mobile markets. The company operates as a diversified industrial conglomerate, leveraging its extensive portfolio of hydraulic, pneumatic, electromechanical, and filtration products to achieve a high rate of cross-selling across its core segments. The current investor narrative is centered on the company's ability to navigate a potential cyclical slowdown in industrial end-markets while demonstrating resilience through its aerospace exposure, with recent financial results and strategic positioning under scrutiny as the market assesses the durability of its margin expansion and cash flow generation.…
PH
Parker Hannifin
$852.56
Investment Opinion: Should I buy PH Today?
Rating & Thesis: Based on a synthesis of the data, Parker-Hannifin is a Hold. The core thesis is that the stock's strong fundamentals and significant analyst-implied upside (~24.5%) are currently counterbalanced by severe technical damage, cyclical headwinds, and a premium valuation that is vulnerable to compression, warranting a neutral stance until the growth trajectory clarifies.
Supporting Evidence: This Hold rating is supported by four key data points. First, the valuation at 25.35x forward earnings is at a premium to the industrials sector, limiting margin of safety. Second, while revenue growth is positive at 9.1% YoY, the deceleration trend is a concern. Third, profitability remains a standout strength with a 16.33% net margin and 25.81% ROE. Fourth, the implied analyst target of ~$1,074 offers attractive potential reward, but the stock must first stabilize its downward momentum, having fallen 10.48% in the past month.
Risks & Conditions: The two biggest risks to this thesis are 1) a deeper-than-expected industrial slowdown crushing earnings estimates, and 2) continued multiple compression eroding the premium valuation. This Hold would upgrade to a Buy if the stock stabilizes above $900, the forward PE compresses below 22x offering better value, or quarterly revenue growth re-accelerates above 10% YoY. It would downgrade to a Sell if the price breaks decisively below the 52-week low of $637.21 or if quarterly revenue growth turns negative. Based on its own historical PE range and sector context, the stock is currently fairly valued to slightly overvalued, pricing in a stable economic environment that appears increasingly uncertain.
Sign up to view all
PH 12-Month Price Forecast
The outlook for PH is balanced but skewed with uncertainty. The company's superb fundamentals provide a solid floor, but the ceiling is limited by cyclical fears and a rich valuation. The base case of a grind higher towards analyst targets is most probable, contingent on the economy avoiding a hard landing. The stance is neutral due to the offsetting forces; the high-quality business is attractive, but the entry point is not compelling given the technical breakdown. We would upgrade to bullish on evidence of earnings stability in the next quarterly report or a further valuation washout (PE below 22x). We would turn bearish on a confirmed break below the 52-week low, signaling a deeper fundamental deterioration.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Parker Hannifin's 12-month outlook, with a consensus price target around $1108.33 and implied upside of +30.0% versus the current price.
Average Target
$1108.33
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$682 - $1108
Analyst target range
Analyst coverage for Parker-Hannifin is robust, with 8 analysts providing estimates, and the institutional sentiment is overwhelmingly bullish, as evidenced by recent actions from major firms like Barclays, Wells Fargo, Citigroup, and JP Morgan all maintaining 'Overweight' or 'Buy' ratings. The consensus average target price is not explicitly provided in the data, but the estimated EPS average for the next period is $42.36, which, when combined with the forward PE of 25.35x, implies a consensus price target in the $1,074 range, suggesting significant potential upside from the current price of $862.72. The target range, inferred from the estimated EPS low of $41.80 and high of $43.44, indicates a relatively tight spread in analyst expectations, signaling strong conviction in the company's earnings power; the high-end scenario likely assumes successful execution on margins and sustained aerospace strength, while the low end may factor in a more pronounced industrial slowdown.
Bulls vs Bears: PH Investment Factors
The evidence presents a classic battle between strong company fundamentals and deteriorating market sentiment. The bull case is anchored in Parker-Hannifin's exceptional profitability, cash generation, and analyst conviction pointing to significant upside. The bear case is driven by a sharp technical breakdown, decelerating growth, and a premium valuation facing cyclical headwinds. Currently, the bearish technical momentum and macro fears appear to have the upper hand, overshadowing the solid underlying financials. The single most important tension in the investment debate is whether the company's robust margins and aerospace exposure can successfully insulate earnings and justify its premium multiple in the face of a potential industrial downturn. The resolution of this tension—specifically, the durability of its margin expansion during a slowdown—will be the primary determinant of the stock's direction.
Bullish
- Strong Profitability and Cash Flow: The company maintains robust margins with a net margin of 16.33% and an operating margin of 21.14%. This operational strength fuels substantial free cash flow generation, with TTM FCF of $3.34 billion, providing ample capital for shareholder returns and strategic investments.
- Analyst Conviction and Upside Potential: Analyst sentiment is overwhelmingly bullish, with major firms maintaining 'Overweight' or 'Buy' ratings. The implied consensus price target of ~$1,074, based on a forward PE of 25.35x and estimated EPS of $42.36, suggests a potential upside of approximately 24.5% from the current price of $862.72.
- Solid Financial Health: Parker-Hannifin's balance sheet is healthy, with a manageable debt-to-equity ratio of 0.70 and a strong return on equity of 25.81%. The company's financial stability is further evidenced by its ability to fund operations and returns primarily through internally generated cash.
- Resilient Aerospace Exposure: The company's diversification into aerospace provides a counter-cyclical buffer against potential slowdowns in its core industrial end-markets. This strategic positioning is a key part of the investor narrative for navigating economic cycles.
Bearish
- Pronounced Technical Downtrend: The stock is down 17.71% from its 52-week high and has lost significant momentum, declining 10.48% over the past month and 13.88% over three months. Trading near the lower end of its 52-week range ($637.21 to $1,034.96), it faces risk of a breakdown below key support.
- Revenue Growth Deceleration: While revenue grew 9.1% YoY in the last quarter, this marks a deceleration from prior periods. The sequential increase from Q1's $5.08 billion to Q2's $5.17 billion (a 1.8% increase) suggests a potential plateau in growth as industrial demand softens.
- Premium Valuation Amid Sector Headwinds: Trading at a forward PE of 25.35x, the stock carries a premium valuation relative to the broader industrials sector. This premium is vulnerable to compression if macroeconomic concerns persist, especially given its beta of 1.182, which amplifies downside during market pullbacks.
- Cyclical End-Market Sensitivity: As a diversified industrial, Parker-Hannifin's core mobile and industrial markets are sensitive to economic cycles. The recent sharp price decline and negative relative strength (-16.08% vs. SPY over 1 month) reflect market fears of an impending industrial slowdown.
PH Technical Analysis
The stock is in a pronounced downtrend from its recent highs, having declined 17.71% from its 52-week high of $1,034.96 and currently trading at $862.72, which places it at approximately 22% of its 52-week range ($637.21 to $1,034.96). This positioning near the lower end of the range suggests the stock is approaching a potential value zone but remains under significant selling pressure, with the risk of a breakdown below the 52-week low. Recent momentum is decisively negative, with the stock down 10.48% over the past month and 13.88% over the past three months, a stark reversal from its positive 28.26% one-year return; this divergence signals a significant loss of bullish momentum, likely driven by macroeconomic concerns impacting the industrials sector. Key technical support is the 52-week low of $637.21, while resistance is the recent high of $1,034.96; a sustained break below support would signal a deeper bearish trend, whereas a recovery above the $900-$950 zone is needed to stabilize the price action. The stock's beta of 1.182 indicates it is approximately 18% more volatile than the broader market, which has been confirmed by its 1-month relative strength of -16.08% against the SPY's 5.6% gain, highlighting its amplified downside risk during market pullbacks.
Beta
1.18
1.18x market volatility
Max Drawdown
-16.7%
Largest decline past year
52-Week Range
$637-$1035
Price range past year
Annual Return
+25.5%
Cumulative gain past year
| Period | PH Return | S&P 500 |
|---|---|---|
| 1m | -13.8% | +3.3% |
| 3m | -14.5% | +6.9% |
| 6m | +4.0% | +12.4% |
| 1y | +25.5% | +23.4% |
| ytd | -4.6% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PH Fundamental Analysis
Revenue growth remains positive but has moderated, with the most recent quarterly revenue of $5.17 billion representing a 9.1% year-over-year increase; however, this marks a deceleration from the stronger growth rates seen in prior quarters, such as the 7.5% sequential increase from Q1's $5.08 billion, indicating a potential plateau in the growth trajectory as industrial demand softens. The company is highly profitable, posting net income of $845 million for the quarter with a robust net margin of 16.33%, supported by a gross margin of 37.32%; while gross margins have remained stable around the 37% level, operating leverage appears to be holding, as evidenced by the operating income of $1.09 billion and an operating margin of 21.14%. Financial health is strong, characterized by substantial cash generation with free cash flow of $768 million for the quarter and trailing twelve-month FCF of $3.34 billion, a manageable debt-to-equity ratio of 0.70, and a solid return on equity of 25.81%, indicating the company funds its operations and shareholder returns primarily through internally generated cash rather than relying on external debt.
Quarterly Revenue
$5.2B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$3.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PH Overvalued?
Given the company's substantial positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 25.38x and a forward PE of 25.35x, with the negligible gap between the two suggesting the market has already priced in stable earnings growth expectations for the near term. Compared to the broader industrials sector, Parker-Hannifin's PE multiple trades at a premium; for context, its current valuation is above its own historical average, as seen in the historical ratios where the PE has ranged from lows near 18x to highs above 32x in recent quarters. The current PE of 25.38x sits near the midpoint of its recent historical range, indicating the stock is neither excessively cheap nor expensive based on its own trading history, but the premium relative to the sector reflects the market's assessment of its superior margins, strong cash flow, and leading market position.
PE
25.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~61x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Parker-Hannifin's primary financial risk is not insolvency—its debt-to-equity of 0.70 and strong FCF generation mitigate that—but rather earnings volatility and margin pressure. The company's net margin, while strong at 16.33%, could face compression if revenue growth decelerates further from the current 9.1% YoY rate, as fixed costs become a larger portion of sales. Furthermore, the valuation (25.35x forward PE) is dependent on sustained high profitability; any miss on the estimated EPS of $42.36 could trigger a significant multiple contraction. The company's diversification is a strength, but it does not eliminate cyclical exposure in its core industrial segments.
Market & Competitive Risks: The most pressing market risk is valuation compression. Trading at a forward PE of 25.35x, PH carries a premium to the industrials sector. If macroeconomic conditions worsen, leading to a sector-wide de-rating, this premium could evaporate, as evidenced by the stock's 1-month underperformance of -16.08% versus the SPY. The stock's beta of 1.182 confirms its amplified sensitivity to market downturns. Competitive risks are more secular, but the company's leading market position and high cross-selling rates provide some defense. The lack of recent news suggests no immediate regulatory or disruptive threats, leaving macro-driven multiple compression as the key external risk.
Worst-Case Scenario: The worst-case scenario involves a severe industrial recession coinciding with a broader market sell-off. This would trigger a double hit: earnings estimates are cut as order rates fall, and the premium PE multiple compresses towards the sector average or the lower end of its historical range (near 18x). A realistic chain of events could see the stock re-test its 52-week low of $637.21, representing a downside of approximately -26% from the current price of $862.72. Given the stock's volatility (beta 1.182) and recent max drawdown of -15.79%, a drawdown of 25-30% in an adverse macro environment is a plausible worst-case outcome for the next 12 months.
FAQ
The key risks of holding PH fall into three categories, ranked by severity: 1) Cyclical/Macro Risk (High): As an industrial with a beta of 1.182, the stock is highly sensitive to economic cycles. A recession could crush earnings and compress its premium multiple. 2) Valuation Risk (Medium): The forward PE of 25.35x leaves little room for error. Any earnings miss or guidance cut could trigger a sharp de-rating. 3) Execution Risk (Low-Medium): While the company has a strong track record, failure to maintain its industry-leading margins (currently 16.33% net) or integrate acquisitions successfully could impair financial results. The technical risk of a breakdown below its 52-week low of $637.21 (-26% downside) is a manifestation of these fundamental risks.
The 12-month forecast for PH is a range of outcomes centered on a base case recovery. The bull case (30% probability) targets $1,074-$1,100, assuming earnings beat estimates and the premium multiple holds. The base case (50% probability) targets $950-$1,074, assuming earnings meet the $42.36 consensus and the PE moderates slightly. The bear case (20% probability) targets $637-$850, assuming an industrial recession triggers earnings cuts and multiple compression. The base case is most likely, hinging on the assumption that the U.S. economy avoids a hard landing. The key to the forecast is the next few quarters of revenue growth and margin data, which will determine which scenario unfolds.
PH stock is fairly valued to slightly overvalued based on current data. Its forward PE of 25.35x sits at a premium to the broader industrials sector, reflecting the market's payment for its superior profitability and market position. Historically, its own PE has ranged from ~18x to over 32x, placing the current multiple near the midpoint—neither excessively cheap nor expensive on its own history. This valuation implies the market expects the company to navigate a potential slowdown without significant earnings degradation. If growth decelerates faster than expected, the current multiple would be considered overvalued; if the company proves resilient, it could be seen as fair or even undervalued relative to its quality.
PH is a good buy for patient, risk-tolerant investors seeking quality industrial exposure, but timing is crucial. The implied 24.5% upside to analyst targets is attractive, and the company's strong fundamentals (16.33% net margin, $3.34B FCF) provide a margin of safety. However, the stock is in a clear downtrend, down over 17% from its high, and carries a premium valuation (25.35x forward PE) that is vulnerable if the economy slows. It is not a good buy for short-term traders or those sensitive to volatility. A disciplined approach would be to wait for technical stabilization above $900 or a more attractive entry point below a 22x PE multiple.
PH is far more suitable for a long-term investment horizon (3-5 years minimum) than for short-term trading. As a cyclical industrial, its business and stock price are influenced by multi-year economic cycles that short-term traders cannot reliably navigate. Its beta of 1.182 and recent volatility demonstrate high short-term risk. However, for long-term investors, the company's durable competitive advantages, strong cash flow generation, and strategic positioning in aerospace provide a foundation for compounding returns through cycles. The low dividend yield (~1%) indicates it is not an income stock, but rather a growth-and-quality play for capital appreciation over time. A concrete suggested minimum holding period is through at least one full economic cycle, or 5+ years.